Clonidine action in spontaneously hypertensive rats (SHR) depends on the GABAergic system function

Area of Science:

• Pharmacology
• Neuroscience
• Cardiovascular Research

Background:

• Hypertension is associated with alterations in the central nervous system.
• The gamma-aminobutyric acid (GABA)ergic system plays a crucial role in regulating blood pressure.
• Clonidine is an antihypertensive drug that acts centrally.

Purpose of the Study:

• To investigate the interaction between clonidine and GABAergic neurotransmission in spontaneously hypertensive rats (SHR) and Wistar Kyoto rats (WKY).
• To determine the role of GABAergic system dysfunction in the hypotensive effects of clonidine.

Main Methods:

• Administration of clonidine alone and in combination with GABA(A) receptor antagonists (bicuculline, picrotoxin) in SHR and WKY rats.
• Measurement of systolic blood pressure (SBP) changes.
• Assessment of GABA turnover rates in specific brain regions (hypothalamus, pons-medulla).

Main Results:

• Clonidine induced a greater hypotensive effect in SHR compared to WKY rats.
• GABA(A) receptor antagonists attenuated the hypotensive effect of clonidine in a dose-dependent manner, with greater efficacy in SHR.
• Clonidine stimulated GABA synthesis, but GABA turnover was slower in SHR, suggesting central GABAergic system dysfunction in hypertension.

Conclusions:

• The enhanced sensitivity to GABA(A) receptor antagonists in SHR indicates a dysfunction in the central GABAergic system contributing to hypertension.
• Clonidine's antihypertensive action may involve the modulation of this compromised GABAergic system.
• The GABAergic system's downregulation in hypertension might be compensated by clonidine's effects.